iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Large Volume Increase – Should You Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw an uptick in trading volume on Thursday . Approximately 568,917 shares were traded during mid-day trading, an increase of 426% from the previous session’s volume of 108,206 shares.The stock last traded at $100.09 and had previously closed at $98.29.

iShares U.S. Pharmaceuticals ETF Stock Performance

The stock has a market capitalization of $1.12 billion, a P/E ratio of 17.75 and a beta of 0.49. The company’s 50-day moving average price is $91.12 and its 200 day moving average price is $88.56.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently bought and sold shares of the business. EFG International AG purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at about $38,000. O Shaughnessy Asset Management LLC boosted its stake in iShares U.S. Pharmaceuticals ETF by 35.0% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after purchasing an additional 120 shares during the period. Assetmark Inc. boosted its stake in iShares U.S. Pharmaceuticals ETF by 203.9% in the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after purchasing an additional 312 shares during the period. Blueline Advisors LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $41,000. Finally, Accent Capital Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $42,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.